87,311 XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 11,694 | 82,984 (0%) | 0% | 6.3 | 73,555 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 3,587 | 29,272 (0%) | 0% | 6.3 | 22,562 | Common Stock |
Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 2,793 | 21,047 (0%) | 0% | 6.3 | 17,568 | Common Stock |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 3,445 | 34,314 (0%) | 0% | 6.3 | 21,669 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 3,548 | 27,414 (0%) | 0% | 6.3 | 22,317 | Common Stock |
Kristin Abate | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.29 per share. | 04 Mar 2025 | 571 | 9,713 (0%) | 0% | 6.3 | 3,592 | Common Stock |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 20,000 | 94,678 (0%) | 0% | 0 | Common Stock | |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,583 | 32,859 (0%) | 0% | 0 | Common Stock | |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 10,833 | 10,833 | - | - | Stock Option (right to buy) | |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 9,166 | 9,166 | - | - | Stock Option (right to buy) | |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,416 | 28,276 (0%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 3,333 | 21,590 (0%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 6,666 | 6,666 | - | - | Stock Option (right to buy) | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,250 | 23,840 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 10,833 | 10,833 | - | - | Stock Option (right to buy) | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,583 | 37,759 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,416 | 33,176 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 9,166 | 9,166 | - | - | Stock Option (right to buy) | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 9,166 | 9,166 | - | - | Stock Option (right to buy) | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 5,000 | 26,379 (0%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,583 | 30,962 (0%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Kristin Abate | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 1,866 | 1,866 | - | - | Stock Option (right to buy) | |
Kristin Abate | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 933 | 10,284 (0%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 18 Feb 2025 | 5,914 | 320,714 (0%) | 0% | 0.6 | 3,726 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 04 Feb 2025 | 4,099 | 1,120,158 (1%) | 0% | 0.6 | 2,664 | Common Stock |
Lori Macomber | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 160,000 | 160,000 (0%) | 0% | 0 | Common Stock | |
Lori Macomber | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 650,000 | 650,000 | - | - | Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 06 Jan 2025 | 4,055 | 1,124,257 (1%) | 0% | 0.8 | 3,175 | Common Stock |
Paulson Richard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.81 per share. | 04 Dec 2024 | 3,620 | 1,128,312 (1%) | 0% | 0.8 | 2,932 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 05 Nov 2024 | 3,675 | 1,131,932 (1%) | 0% | 0.9 | 3,346 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 04 Oct 2024 | 3,607 | 1,135,607 (1%) | 0% | 0.9 | 3,172 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 7,050 | 391,054 (0%) | 0% | 0.7 | 5,089 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 3,667 | 1,139,214 (1%) | 0% | 0.7 | 2,647 | Common Stock |
Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 3,971 | 273,881 (0%) | 0% | 0.7 | 2,866 | Common Stock |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Sep 2024 | 5,356 | 404,051 (0%) | 0% | 0.7 | 3,866 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 06 Aug 2024 | 3,608 | 1,142,881 (1%) | 0% | 0.9 | 3,355 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 30 Jul 2024 | 2,883 | 326,628 (0%) | 0% | 1.1 | 3,056 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 05 Jul 2024 | 3,616 | 1,146,489 (1%) | 0% | 0.9 | 3,077 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 05 Jun 2024 | 463,518 | 346,615 (0%) | 0% | 1.0 | 444,143 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 05 Jun 2024 | 2,240 | 0 (0%) | 0% | 1.0 | 2,130 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 05 Jun 2024 | 229,308 | 0 (0%) | 0% | 1.0 | 218,003 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 05 Jun 2024 | 1,145 | 2,240 (0%) | 0% | 1.0 | 1,125 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 05 Jun 2024 | 117,307 | 229,308 (0%) | 0% | 1.0 | 115,289 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 05 Jun 2024 | 4,526 | 3,385 (0%) | 0% | 1.0 | 4,337 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 04 Jun 2024 | 652 | 398,104 (0%) | 0% | 1.0 | 645 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 04 Jun 2024 | 3,592 | 1,150,105 (1%) | 0% | 1.0 | 3,556 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 3,298 | 7,911 (0%) | 0% | 1.0 | 3,140 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 31 May 2024 | 357,256 | 1,147,875 (1%) | 0% | 1.0 | 357,506 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 1,976 | 14,697 (0%) | 0% | 1.0 | 1,885 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 202,418 | 1,505,131 (2%) | 0% | 1.0 | 193,107 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 337,742 | 810,133 (1%) | 0% | 1.0 | 321,564 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 31 May 2024 | 3,488 | 11,209 (0%) | 0% | 1.0 | 3,490 | Common Stock |
Barry E. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Garen G. Bohlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Zhen Su | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 50,587 | 50,587 | - | - | Nonstatutory Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 06 May 2024 | 3,576 | 1,153,697 (1%) | 0% | 1.1 | 4,041 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 22 Apr 2024 | 6,789 | 342,931 (0%) | 0% | 1.2 | 7,943 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 04 Apr 2024 | 3,563 | 1,157,273 (1%) | 0% | 1.3 | 4,596 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 05 Mar 2024 | 3,573 | 1,160,836 (1%) | 0% | 1.3 | 4,645 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 6,162 | 398,756 (0%) | 0% | 1.2 | 7,394 | Common |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 27,687 | 404,918 (0%) | 0% | 1.2 | 32,394 | Common |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 80,470 | 1,183,783 (1%) | 0% | 1.2 | 94,150 | Common |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 19,374 | 1,164,409 (1%) | 0% | 1.2 | 23,249 | Common |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 15,667 | 355,689 (0%) | 0% | 1.2 | 18,330 | Common |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 5,969 | 349,720 (0%) | 0% | 1.2 | 7,163 | Common |
Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 16,973 | 281,428 (0%) | 0% | 1.2 | 19,858 | Common |
Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 3,576 | 277,852 (0%) | 0% | 1.2 | 4,291 | Common |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 21,840 | 398,618 (0%) | 0% | 1.2 | 25,553 | Common |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 5,109 | 393,509 (0%) | 0% | 1.2 | 6,131 | Common |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 29 Feb 2024 | 16,311 | 335,666 (0%) | 0% | 1.2 | 19,084 | Common |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 29 Feb 2024 | 6,155 | 329,511 (0%) | 0% | 1.2 | 7,386 | Common |
Roshan Cheng Sohanya | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 198,959 | 420,458 (0%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 188,205 | 351,977 (0%) | 0% | 0 | Common Stock | |
Paulson Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 442,800 | 1,264,253 (1%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 147,000 | 298,401 (0%) | 0% | 0 | Common Stock | |
Rangwala Reshma | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 198,959 | 371,356 (0%) | 0% | 0 | Common Stock | |
Mason Michael | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 188,205 | 432,605 (0%) | 0% | 0 | Common Stock | |
Mason Michael | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 27 Feb 2024 | 2,545 | 244,400 (0%) | 0% | 1.3 | 3,369 | Common Stock |
Poulton Stuart | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.40 per share. | 15 Feb 2024 | 99 | 163,772 (0%) | 0% | 1.4 | 139 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 15 Feb 2024 | 5,748 | 163,871 (0%) | 0% | 1.3 | 7,645 | Common Stock |
Mason Michael | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 06 Feb 2024 | 4,205 | 246,945 (0%) | 0% | 1.6 | 6,671 | Common Stock |
Paulson Richard | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 06 Feb 2024 | 4,012 | 821,453 (1%) | 0% | 1.6 | 6,365 | Common Stock |
Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,167 | 221,499 (0%) | 0% | 0 | Common Stock | |
Mason Michael | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 13,333 | 251,150 (0%) | 0% | 0 | Common Stock | |
Mano Michael | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 9,167 | 151,401 (0%) | 0% | 0 | Common Stock | |
Rangwala Reshma | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,167 | 172,397 (0%) | 0% | 0 | Common Stock | |
Paulson Richard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 42,000 | 825,465 (1%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 13,333 | 169,619 (0%) | 0% | 0 | Common Stock | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.82 per share. | 04 Jan 2024 | 4,114 | 783,465 (1%) | 0% | 0.8 | 3,373 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 04 Dec 2023 | 3,622 | 787,579 (1%) | 0% | 0.8 | 2,861 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 07 Aug 2023 | 3,722 | 802,018 (1%) | 0% | 1.7 | 6,402 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 1.70 per share. | 28 Jul 2023 | 2,845 | 156,286 (0%) | 0% | 1.7 | 4,837 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 05 Jul 2023 | 3,538 | 805,740 (1%) | 0% | 1.7 | 6,085 | Common Stock |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 08 Jun 2023 | 1,839 | 211,501 (0%) | 0% | 2.4 | 4,322 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 05 Jun 2023 | 3,536 | 809,278 (1%) | 0% | 2.2 | 7,922 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 2.22 per share. | 02 Jun 2023 | 631 | 244,730 (0%) | 0% | 2.2 | 1,401 | Common Stock |
Barry E. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Garen G. Bohlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Peter K. Honig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 04 May 2023 | 3,805 | 812,814 (1%) | 0% | 3.4 | 12,753 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.05 per share. | 20 Apr 2023 | 6,655 | 158,230 (0%) | 0% | 4.1 | 26,953 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 20 Apr 2023 | 115 | 164,885 (0%) | 0% | 4.0 | 463 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.97 per share. | 04 Apr 2023 | 3,497 | 816,619 (1%) | 0% | 4.0 | 13,883 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 06 Mar 2023 | 3,506 | 820,116 (1%) | 0% | 3.2 | 11,079 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 95,000 | 256,566 (0%) | 0% | 0 | Common Stock | |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 11,205 | 245,361 (0%) | 0% | 3.0 | 33,942 | Common Stock |
Stephen Mitchener | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 60,000 | 134,670 (0%) | 0% | 0 | Common Stock | |
Stephen Mitchener | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 6,357 | 128,313 (0%) | 0% | 3.0 | 19,257 | Common Stock |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 252,000 | 856,655 (1%) | 0% | 0 | Common Stock | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 33,033 | 823,622 (1%) | 0% | 3.0 | 100,064 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 100,000 | 165,000 (0%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 6,878 | 146,122 (0%) | 0% | 3.0 | 20,835 | Common Stock |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 70,000 | 153,000 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.03 per share. | 28 Feb 2023 | 11,239 | 210,687 (0%) | 0% | 3.0 | 34,045 | Common Stock |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 100,000 | 221,926 (0%) | 0% | 0 | Common Stock | |
Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 95,000 | 159,131 (0%) | 0% | 0 | Common Stock | |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 3.04 per share. | 27 Feb 2023 | 2,802 | 161,566 (0%) | 0% | 3.0 | 8,509 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.19 per share. | 15 Feb 2023 | 5,665 | 64,335 (0%) | 0% | 3.2 | 18,071 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.16 per share. | 15 Feb 2023 | 196 | 64,131 (0%) | 0% | 3.2 | 619 | Common Stock |
Stuart Poulton | EVP, Chief Development Officer | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 15 Feb 2023 | 8 | 64,327 (0%) | 0% | 3.3 | 26 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 06 Feb 2023 | 4,141 | 164,368 (0%) | 0% | 3.4 | 14,079 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 06 Feb 2023 | 3,950 | 604,655 (0%) | 0% | 3.4 | 13,430 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.27 per share. | 04 Jan 2023 | 3,922 | 608,605 (0%) | 0% | 3.3 | 12,825 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 05 Dec 2022 | 3,490 | 612,527 (0%) | 0% | 5.2 | 18,043 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 04 Nov 2022 | 3,493 | 616,017 (0%) | 0% | 4.5 | 15,858 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.87 per share. | 04 Oct 2022 | 3,488 | 619,510 (0%) | 0% | 5.9 | 20,475 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.25 per share. | 08 Sep 2022 | 16 | 626,461 (0%) | 0% | 5.3 | 84 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 08 Sep 2022 | 3,463 | 622,998 (0%) | 0% | 5.2 | 18,111 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Michael Mason | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 168,509 (0%) | 0% | 0 | Common Stock | |
Stephen Mitchener | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Stephen Mitchener | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 20,000 | 70,546 (0%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 20,000 | 83,000 (0%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 30,000 | 119,949 (0%) | 0% | 0 | Common Stock | |
Barry E. Greene | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 7,576 | 0 | - | - | Stock Option (right to buy) | |
Barry E. Greene | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.48 per share. | 11 Aug 2022 | 7,576 | 13,606 (0%) | 0% | 1.5 | 11,250 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 04 Aug 2022 | 2,314 | 626,477 (0%) | 0% | 4.5 | 10,367 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 08 Jul 2022 | 2,115 | 628,791 (0%) | 0% | 5.2 | 10,948 | Common Stock |
Sohanya Roshan Cheng | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.20 per share. | 13 Jun 2022 | 1,485 | 89,949 (0%) | 0% | 5.2 | 7,722 | Common Stock |
Sohanya Roshan Cheng | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.35 per share. | 13 Jun 2022 | 66 | 91,434 (0%) | 0% | 5.3 | 353 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Jun 2022 | 322,825 | 1,918,298 (2%) | 0% | 6.5 | 2,099,428 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Jun 2022 | 13 | 16,673 (0%) | 0% | 6 | 78 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Jun 2022 | 1,294 | 1,707,549 (2%) | 0% | 6.0 | 7,766 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 08 Jun 2022 | 2,045 | 16,686 (0%) | 0% | 6.2 | 12,638 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 08 Jun 2022 | 209,455 | 1,708,843 (2%) | 0% | 6.2 | 1,294,390 | Common Stock |
Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Jun 2022 | 3,152 | 18,731 (0%) | 0% | 6.5 | 20,498 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.76 per share. | 07 Jun 2022 | 2,542 | 630,906 (0%) | 0% | 5.8 | 14,642 | Common Stock |
Michael Mason | EVP, CFO, Treasurer | Sale of securities on an exchange or to another person at price $ 6.04 per share. | 03 Jun 2022 | 598 | 138,512 (0%) | 0% | 6.0 | 3,612 | Common Stock |
Michael Mason | EVP, CFO, Treasurer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 03 Jun 2022 | 3 | 138,509 (0%) | 0% | 6 | 18 | Common Stock |
Barry E. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Garen G. Bohlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Peter K. Honig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 10,995 | 10,995 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 04 May 2022 | 633 | 661,317 (1%) | 0% | 6.3 | 3,963 | Common Stock |
Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 04 May 2022 | 27,869 | 633,448 (0%) | 0% | 6.2 | 173,546 | Common Stock |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Reshma Rangwala | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 65,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
Sharon Shacham | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 60,000 | 958,131 (1%) | 0% | 0 | Common Stock | |
Sharon Shacham | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 6,226 | 898,131 (1%) | 0% | 10.2 | 63,739 | Common Stock |
Michael Glen Kauffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
Michael Glen Kauffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 21,000 | 719,983 (1%) | 0% | 0 | Common Stock | |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 6,226 | 713,757 (1%) | 0% | 10.2 | 63,739 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 111,600 | 111,600 | - | - | Stock Option (right to buy) | |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 2,398 | 139,110 (0%) | 0% | 10.2 | 24,550 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 88,200 | 141,508 (0%) | 0% | 0 | Common Stock | |
Sharon Shacham | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
Sharon Shacham | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 21,000 | 719,983 (1%) | 0% | 0 | Common Stock | |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 6,226 | 713,757 (1%) | 0% | 10.2 | 63,739 | Common Stock |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 6,226 | 898,131 (1%) | 0% | 10.2 | 63,739 | Common Stock |
Ran Frenkel | EVP, Chief Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 68,250 | 169,953 (0%) | 0% | 0 | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
Ran Frenkel | EVP, Chief Dev. Officer | Sale of securities on an exchange or to another person at price $ 10.24 per share. | 28 Feb 2022 | 1,663 | 168,290 (0%) | 0% | 10.2 | 17,025 | Common Stock |
Stephen Mitchener | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 59,400 | 59,400 | - | - | Stock Option (right to buy) | |
Stephen Mitchener | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 47,250 | 50,546 (0%) | 0% | 0 | Common Stock | |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 360,000 | 360,000 | - | - | Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 288,750 | 661,950 (1%) | 0% | 0 | Common Stock | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 81,000 | 81,000 | - | - | Stock Option (right to buy) | |
Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 63,000 | 63,000 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 84,000 | 91,500 (0%) | 0% | 0 | Common Stock | |
Sohanya Roshan Cheng | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 108,000 | 108,000 | - | - | Stock Option (right to buy) | |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 9,079 | 698,983 (1%) | 0% | 12.1 | 110,068 | Common Stock |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 9,088 | 904,357 (1%) | 0% | 12.1 | 110,177 | Common Stock |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 9,079 | 698,983 (1%) | 0% | 12.1 | 110,068 | Common Stock |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 9,088 | 904,357 (1%) | 0% | 12.1 | 110,177 | Common Stock |
Ran Frenkel | EVP, Chief Dev. Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 2,929 | 101,703 (0%) | 0% | 12.1 | 35,509 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 17 Feb 2022 | 1,306 | 129,450 (0%) | 0% | 12.1 | 15,833 | Common Stock |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 6,707 | 913,445 (1%) | 0% | 9.9 | 66,144 | Common Stock |
Michael Glen Kauffman | Director | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 6,764 | 708,062 (1%) | 0% | 9.9 | 66,707 | Common Stock |
Michael Mason | EVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 3,947 | 53,308 (0%) | 0% | 9.9 | 38,925 | Common Stock |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 6,764 | 708,062 (1%) | 0% | 9.9 | 66,707 | Common Stock |
Sharon Shacham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 6,707 | 913,445 (1%) | 0% | 9.9 | 66,144 | Common Stock |
Ran Frenkel | EVP, Chief Dev. Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 1,991 | 104,632 (0%) | 0% | 9.9 | 19,635 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 07 Feb 2022 | 1,704 | 130,756 (0%) | 0% | 9.9 | 16,805 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.73 per share. | 12 Jul 2021 | 665 | 131,137 (0%) | 0% | 9.7 | 6,470 | Common Stock |
Sohanya Roshan Cheng | SVP Sales & Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 125,000 | 125,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Sohanya Roshan Cheng | SVP Sales & Commercial Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock | |
Stephen Mitchener | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.29 per share. | 02 Jun 2021 | 528 | 2,472 (0%) | 0% | 9.3 | 4,905 | Common Stock |
Michael Mason | EVP, CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 5,500 | 57,255 (0%) | 0% | 0 | Common Stock | |
Michael Mason | EVP, CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
Stephen Mitchener | SVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2021 | 1,500 | 1,500 | - | - | Restricted Stock Units | |
Stephen Mitchener | SVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2021 | 1,500 | 3,000 (0%) | 0% | - | Common Stock | |
Barry E. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Garen G. Bohlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Mikael Dolsten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
Jatin Shah | EVP, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 8.60 per share. | 07 May 2021 | 23,250 | 131,802 (0%) | 0% | 8.6 | 199,992 | Common Stock |
Garen G. Bohlin | Director | Purchase of securities on an exchange or from another person at price $ 7.82 per share. | 06 May 2021 | 4,000 | 4,000 (0%) | 0% | 7.8 | 31,280 | Common Stock |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 559,800 | 559,800 | - | - | Stock Option (right to buy) | |
Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 373,200 | 373,200 (0%) | 0% | 0 | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.39 per share. | 18 Mar 2021 | 4,000 | 714,826 (1%) | 0% | 12.4 | 49,553 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 12.39 per share. | 18 Mar 2021 | 4,000 | 714,826 (1%) | 0% | 12.4 | 49,553 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 57,200 | 718,826 (1%) | 0% | 0 | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 57,200 | 920,152 (1%) | 0% | 0 | Common Stock | |
Tanya Lewis | EVP, Chief Reg. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 22,013 | 45,401 (0%) | 0% | 0 | Common Stock | |
Tanya Lewis | EVP, Chief Reg. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 59,968 | 59,968 | - | - | Stock Option (right to buy) | |
Michael Mason | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 22,013 | 51,755 (0%) | 0% | 0 | Common Stock | |
Michael Mason | SVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 59,968 | 59,968 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 57,200 | 920,152 (1%) | 0% | 0 | Common Stock | |
Sharon Shacham | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 57,200 | 718,826 (1%) | 0% | 0 | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 22,013 | 104,439 (0%) | 0% | 0 | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 59,968 | 59,968 | - | - | Stock Option (right to buy) | |
John Demaree | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 15,849 | 23,995 (0%) | 0% | 0 | Common Stock | |
John Demaree | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 43,177 | 43,177 | - | - | Stock Option (right to buy) | |
Jatin Shah | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 59,968 | 59,968 | - | - | Stock Option (right to buy) | |
Jatin Shah | EVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 22,013 | 107,691 (0%) | 0% | 0 | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 9,495 | 575,126 (0%) | 0% | 14.8 | 140,822 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 9,495 | 776,452 (1%) | 0% | 14.8 | 140,822 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 9,495 | 776,452 (1%) | 0% | 14.8 | 140,822 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 9,495 | 575,126 (0%) | 0% | 14.8 | 140,822 | Common Stock |
Ran Frenkel | EVP, Chief Dev. Officer | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 2,887 | 46,126 (0%) | 0% | 14.8 | 42,818 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 18 Feb 2021 | 1,186 | 51,791 (0%) | 0% | 14.8 | 17,590 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 6,601 | 562,821 (0%) | 0% | 15.5 | 102,441 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 43,600 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 43,600 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 785,947 (1%) | 0% | - | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 6,642 | 764,147 (1%) | 0% | 15.5 | 103,077 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 584,621 (0%) | 0% | - | Common Stock | |
Tanya Lewis | EVP, Chief Reg. Affairs | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 2,046 | 4,143 (0%) | 0% | 15.5 | 31,752 | Common Stock |
Michael Mason | SVP, CFO & Treasurer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 2,858 | 5,292 (0%) | 0% | 15.5 | 44,354 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 6,642 | 764,147 (1%) | 0% | 15.5 | 103,077 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 43,600 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 43,600 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 584,621 (0%) | 0% | - | Common Stock | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 6,601 | 562,821 (0%) | 0% | 15.5 | 102,441 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 21,800 | 785,947 (1%) | 0% | - | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 9,675 | 19,350 | - | - | Restricted Stock Units | |
Ran Frenkel | EVP, Chief Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 9,675 | 49,013 (0%) | 0% | - | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 2,046 | 39,338 (0%) | 0% | 15.5 | 31,752 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,850 | 9,700 | - | - | Restricted Stock Units | |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 4,850 | 52,977 (0%) | 0% | - | Common Stock | |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 11 Feb 2021 | 1,748 | 48,127 (0%) | 0% | 15.5 | 27,127 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 770,789 (1%) | 0% | - | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 42,900 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 42,900 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 569,422 (0%) | 0% | - | Common Stock | |
Tanya Lewis | EVP, Chief Reg. Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 6,189 (0%) | 0% | - | Common Stock | |
Tanya Lewis | EVP, Chief Reg. Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 16,950 | - | - | Restricted Stock Units | |
Michael Mason | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 8,150 | 24,450 | - | - | Restricted Stock Units | |
Michael Mason | SVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 8,150 | 8,150 (0%) | 0% | - | Common Stock | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 770,789 (1%) | 0% | - | Common Stock | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 42,900 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 42,900 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 14,300 | 569,422 (0%) | 0% | - | Common Stock | |
Ran Frenkel | EVP, Chief Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 16,950 | - | - | Restricted Stock Units | |
Ran Frenkel | EVP, Chief Dev. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 41,384 (0%) | 0% | - | Common Stock | |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 49,875 (0%) | 0% | - | Common Stock | |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2021 | 5,650 | 16,950 | - | - | Restricted Stock Units | |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.43 per share. | 18 Dec 2020 | 5,000 | 5,000 (0%) | 0% | 5.4 | 27,150 | Common Stock |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 18 Dec 2020 | 5,000 | 0 (0%) | 0% | 18 | 90,000 | Common Stock |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 16.04 per share. | 07 Dec 2020 | 5,000 | 5,000 (0%) | 0% | 16.0 | 80,223 | Common Stock |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 07 Dec 2020 | 5,000 | 10,000 (0%) | 0% | 16.0 | 80,227 | Common Stock |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.43 per share. | 07 Dec 2020 | 20,000 | 20,000 (0%) | 0% | 5.4 | 108,600 | Common Stock |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 16.05 per share. | 07 Dec 2020 | 5,000 | 15,000 (0%) | 0% | 16.0 | 80,231 | Common Stock |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 20,000 | 5,000 | - | - | Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 16.14 per share. | 07 Dec 2020 | 5,000 | 0 (0%) | 0% | 16.1 | 80,704 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.45 per share. | 01 Dec 2020 | 78,124 | 82,647 (0%) | 0% | 10.5 | 816,396 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 58,937 | 16,842 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 78,124 | 46,876 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 01 Dec 2020 | 58,937 | 4,523 (0%) | 0% | 17.4 | 1,022,557 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.39 per share. | 01 Dec 2020 | 58,937 | 63,460 (0%) | 0% | 10.4 | 612,355 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.66 per share. | 01 Dec 2020 | 78,124 | 4,523 (0%) | 0% | 17.7 | 1,379,670 | Common Stock |
Chen Schor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2020 | 32,800 | 32,800 | - | - | Nonstatutory Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 14.92 per share. | 02 Nov 2020 | 772 | 4,523 (0%) | 0% | 14.9 | 11,518 | Common Stock |
Tanya Lewis | EVP,Chief Reg.&Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2020 | 765 | 2,295 | - | - | Restricted Stock Units | |
Tanya Lewis | EVP,Chief Reg.&Quality Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 28 Oct 2020 | 226 | 539 (0%) | 0% | 15.6 | 3,521 | Common Stock |
Tanya Lewis | EVP,Chief Reg.&Quality Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2020 | 765 | 765 (0%) | 0% | - | Common Stock | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2020 | 38,550 | 64,250 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2020 | 721 | 75,779 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 17.20 per share. | 13 Oct 2020 | 721 | 4,649 (0%) | 0% | 17.2 | 12,401 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.39 per share. | 13 Oct 2020 | 721 | 5,370 (0%) | 0% | 10.4 | 7,491 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 16.85 per share. | 13 Oct 2020 | 38,550 | 4,649 (0%) | 0% | 16.9 | 649,568 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.21 per share. | 13 Oct 2020 | 38,550 | 43,199 (0%) | 0% | 9.2 | 355,046 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 12 Oct 2020 | 1,424 | 757,913 (1%) | 0% | 0.0 | 47 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 12 Oct 2020 | 6,076 | 763,989 (1%) | 0% | 0.0 | 201 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.89 per share. | 12 Oct 2020 | 7,500 | 756,489 (1%) | 0% | 14.9 | 111,683 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2020 | 6,076 | 0 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2020 | 1,424 | 0 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 12 Oct 2020 | 1,424 | 757,913 (1%) | 0% | 0.0 | 47 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2020 | 1,424 | 0 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 14.89 per share. | 12 Oct 2020 | 7,500 | 756,489 (1%) | 0% | 14.9 | 111,683 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 12 Oct 2020 | 6,076 | 763,989 (1%) | 0% | 0.0 | 201 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2020 | 6,076 | 0 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.54 per share. | 08 Sep 2020 | 10,054 | 14,703 (0%) | 0% | 6.5 | 65,753 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 14.98 per share. | 08 Sep 2020 | 10,054 | 4,649 (0%) | 0% | 15.0 | 150,609 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2020 | 10,054 | 0 | - | - | Stock Option (right to buy) | |
Christy J. Oliger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 32,800 | 32,800 | - | - | Nonstatutory Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 1,477 | 6,076 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Aug 2020 | 1,477 | 756,489 (1%) | 0% | 15 | 22,155 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 17 Aug 2020 | 1,477 | 757,966 (1%) | 0% | 0.0 | 49 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 17 Aug 2020 | 1,477 | 757,966 (1%) | 0% | 0.0 | 49 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Aug 2020 | 1,477 | 756,489 (1%) | 0% | 15 | 22,155 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2020 | 1,477 | 6,076 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jul 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2020 | 7,500 | 1,424 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 15 Jul 2020 | 7,500 | 756,489 (1%) | 0% | 19.4 | 145,723 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2020 | 7,500 | 1,424 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 15 Jul 2020 | 7,500 | 756,489 (1%) | 0% | 19.4 | 145,723 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jul 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2020 | 2,413 | 7,237 | - | - | Restricted Stock Units | |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.46 per share. | 11 Jul 2020 | 589 | 43,229 (0%) | 0% | 19.5 | 11,462 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2020 | 2,413 | 43,172 (0%) | 0% | - | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.98 per share. | 09 Jul 2020 | 7,200 | 555,422 (0%) | 0% | 19.0 | 136,627 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2020 | 7,500 | 377,803 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2020 | 7,500 | 333,561 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.53 per share. | 09 Jul 2020 | 7,500 | 756,489 (1%) | 0% | 19.5 | 146,487 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jul 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.71 per share. | 09 Jul 2020 | 300 | 555,122 (0%) | 0% | 19.7 | 5,912 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jul 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 19.53 per share. | 09 Jul 2020 | 7,500 | 756,489 (1%) | 0% | 19.5 | 146,487 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2020 | 7,500 | 333,561 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2020 | 7,500 | 377,803 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 19.71 per share. | 09 Jul 2020 | 300 | 555,122 (0%) | 0% | 19.7 | 5,912 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 18.98 per share. | 09 Jul 2020 | 7,200 | 555,422 (0%) | 0% | 19.0 | 136,627 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jul 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jul 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 22 Jun 2020 | 7,500 | 756,489 (1%) | 0% | 20 | 150,000 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2020 | 7,500 | 8,924 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 22 Jun 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 22 Jun 2020 | 7,500 | 756,489 (1%) | 0% | 20 | 150,000 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2020 | 7,500 | 8,924 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 22 Jun 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jun 2020 | 357 | 756,846 (1%) | 0% | 0.0 | 12 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 357 | 0 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 7,143 | 16,424 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.20 per share. | 15 Jun 2020 | 357 | 756,489 (1%) | 0% | 16.2 | 5,783 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.38 per share. | 15 Jun 2020 | 7,143 | 756,489 (1%) | 0% | 16.4 | 116,996 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jun 2020 | 7,143 | 763,632 (1%) | 0% | 0.0 | 236 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jun 2020 | 7,143 | 763,632 (1%) | 0% | 0.0 | 236 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 357 | 0 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 7,143 | 16,424 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 16.20 per share. | 15 Jun 2020 | 357 | 756,489 (1%) | 0% | 16.2 | 5,783 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 Jun 2020 | 357 | 756,846 (1%) | 0% | 0.0 | 12 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 16.38 per share. | 15 Jun 2020 | 7,143 | 756,489 (1%) | 0% | 16.4 | 116,996 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.13 per share. | 09 Jun 2020 | 7,500 | 555,122 (0%) | 0% | 18.1 | 135,944 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 7,500 | 385,303 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 7,500 | 341,061 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 09 Jun 2020 | 7,500 | 756,489 (1%) | 0% | 18.5 | 138,746 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jun 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jun 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 09 Jun 2020 | 7,500 | 756,489 (1%) | 0% | 18.5 | 138,746 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 7,500 | 341,061 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2020 | 7,500 | 385,303 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 18.13 per share. | 09 Jun 2020 | 7,500 | 555,122 (0%) | 0% | 18.1 | 135,944 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jun 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Jun 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Barry E. Greene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Garen G. Bohlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Mikael Dolsten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 May 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 7,500 | 357 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 7,500 | 7,857 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.65 per share. | 15 May 2020 | 7,500 | 756,489 (1%) | 0% | 18.6 | 139,841 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 May 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 15 May 2020 | 7,500 | 756,489 (1%) | 0% | 20 | 150,000 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 18.65 per share. | 15 May 2020 | 7,500 | 756,489 (1%) | 0% | 18.6 | 139,841 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 May 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 15 May 2020 | 7,500 | 763,989 (1%) | 0% | 0.0 | 248 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 15 May 2020 | 7,500 | 756,489 (1%) | 0% | 20 | 150,000 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 7,500 | 7,857 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2020 | 7,500 | 357 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 07 May 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2020 | 7,500 | 392,803 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2020 | 7,500 | 348,561 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.63 per share. | 07 May 2020 | 7,500 | 756,489 (1%) | 0% | 19.6 | 147,205 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 07 May 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.63 per share. | 07 May 2020 | 7,500 | 555,122 (0%) | 0% | 19.6 | 147,209 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2020 | 7,500 | 348,561 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2020 | 7,500 | 392,803 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 19.63 per share. | 07 May 2020 | 7,500 | 555,122 (0%) | 0% | 19.6 | 147,209 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 07 May 2020 | 7,500 | 562,622 (0%) | 0% | 4.8 | 35,640 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 19.63 per share. | 07 May 2020 | 7,500 | 756,489 (1%) | 0% | 19.6 | 147,205 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 07 May 2020 | 7,500 | 763,989 (1%) | 0% | 4.8 | 35,640 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2020 | 2,946 | 10,054 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 May 2020 | 2,946 | 4,649 (0%) | 0% | 20 | 58,920 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.54 per share. | 07 May 2020 | 2,946 | 7,595 (0%) | 0% | 6.5 | 19,267 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 19.62 per share. | 07 May 2020 | 6,714 | 4,649 (0%) | 0% | 19.6 | 131,707 | Common Stock |
Ran Frenkel | Chief Dev Operations Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 07 May 2020 | 1,974 | 35,088 (0%) | 0% | 20 | 39,480 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.64 per share. | 08 Apr 2020 | 10,000 | 555,122 (0%) | 0% | 20.6 | 206,404 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 10,000 | 400,303 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 10,000 | 356,061 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 08 Apr 2020 | 10,000 | 756,489 (1%) | 0% | 18.6 | 186,115 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Apr 2020 | 10,000 | 766,489 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Apr 2020 | 10,000 | 565,122 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 08 Apr 2020 | 10,000 | 756,489 (1%) | 0% | 18.6 | 186,115 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 10,000 | 356,061 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 10,000 | 400,303 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 20.64 per share. | 08 Apr 2020 | 10,000 | 555,122 (0%) | 0% | 20.6 | 206,404 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Apr 2020 | 10,000 | 565,122 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 08 Apr 2020 | 10,000 | 766,489 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Barry E. Greene | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2020 | 3,030 | 0 | - | - | Stock Option (right to buy) | |
Barry E. Greene | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.03 per share. | 13 Mar 2020 | 3,030 | 6,030 (0%) | 0% | 0.0 | 100 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Mar 2020 | 10,000 | 565,122 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2020 | 10,000 | 410,303 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2020 | 10,000 | 366,061 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.38 per share. | 09 Mar 2020 | 3,000 | 756,489 (1%) | 0% | 22.4 | 67,141 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 09 Mar 2020 | 7,000 | 759,489 (1%) | 0% | 22.6 | 158,054 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Mar 2020 | 10,000 | 766,489 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.64 per share. | 09 Mar 2020 | 2,068 | 555,122 (0%) | 0% | 22.6 | 46,821 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.11 per share. | 09 Mar 2020 | 7,932 | 557,190 (0%) | 0% | 22.1 | 175,365 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Mar 2020 | 10,000 | 766,489 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2020 | 10,000 | 366,061 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2020 | 10,000 | 410,303 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 22.64 per share. | 09 Mar 2020 | 2,068 | 555,122 (0%) | 0% | 22.6 | 46,821 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 22.11 per share. | 09 Mar 2020 | 7,932 | 557,190 (0%) | 0% | 22.1 | 175,365 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 09 Mar 2020 | 10,000 | 565,122 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 22.38 per share. | 09 Mar 2020 | 3,000 | 756,489 (1%) | 0% | 22.4 | 67,141 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 09 Mar 2020 | 7,000 | 759,489 (1%) | 0% | 22.6 | 158,054 | Common Stock |
Richard Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2020 | 50,000 | 50,000 | - | - | Nonstatutory Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 02 Mar 2020 | 5,000 | 0 (0%) | 0% | 23.5 | 117,500 | Common Stock |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2020 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.06 per share. | 02 Mar 2020 | 5,000 | 5,000 (0%) | 0% | 8.1 | 40,300 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 02 Mar 2020 | 10,000 | 19,367 (0%) | 0% | 28 | 280,000 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 02 Mar 2020 | 7,500 | 29,367 (0%) | 0% | 23.5 | 176,250 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.39 per share. | 02 Mar 2020 | 26,500 | 36,867 (0%) | 0% | 10.4 | 275,335 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2020 | 26,500 | 76,500 | - | - | Stock Option (right to buy) | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 02 Mar 2020 | 9,000 | 10,367 (0%) | 0% | 24.0 | 216,029 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 8,817 | 555,122 (0%) | 0% | 16.5 | 145,321 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 8,817 | 756,489 (1%) | 0% | 16.5 | 145,321 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 8,817 | 756,489 (1%) | 0% | 16.5 | 145,321 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 8,817 | 555,122 (0%) | 0% | 16.5 | 145,321 | Common Stock |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 2,961 | 10,367 (0%) | 0% | 16.5 | 48,803 | Common Stock |
Ran Frenkel | Chief Dev Operations Officer | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 2,975 | 36,066 (0%) | 0% | 16.5 | 49,034 | Common Stock |
Jatin Shah | EVP, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.48 per share. | 19 Feb 2020 | 1,375 | 40,759 (0%) | 0% | 16.5 | 22,663 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 65,400 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 563,939 (0%) | 0% | - | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 765,306 (1%) | 0% | - | Common Stock | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 65,400 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 65,400 | - | - | Restricted Stock Units | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 765,306 (1%) | 0% | - | Common Stock | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 563,939 (0%) | 0% | - | Common Stock | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 21,800 | 65,400 | - | - | Restricted Stock Units | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 9,675 | 29,025 | - | - | Restricted Stock Units | |
Christopher Brett Primiano | EVP, CBO, GC & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 9,675 | 13,328 (0%) | 0% | - | Common Stock | |
Ran Frenkel | Chief Dev Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 9,675 | 29,025 | - | - | Restricted Stock Units | |
Ran Frenkel | Chief Dev Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 9,675 | 39,041 (0%) | 0% | - | Common Stock | |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 4,850 | 42,134 (0%) | 0% | - | Common Stock | |
Jatin Shah | EVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2020 | 4,850 | 14,550 | - | - | Restricted Stock Units | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2020 | 10,000 | 376,061 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2020 | 10,000 | 420,303 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 10 Feb 2020 | 10,000 | 552,139 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 10 Feb 2020 | 10,000 | 753,506 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 17.43 per share. | 10 Feb 2020 | 10,000 | 542,139 (0%) | 0% | 17.4 | 174,294 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.93 per share. | 10 Feb 2020 | 10,000 | 743,506 (1%) | 0% | 16.9 | 169,327 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2020 | 10,000 | 376,061 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2020 | 10,000 | 420,303 | - | - | Stock Option (right to buy) | |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 17.43 per share. | 10 Feb 2020 | 10,000 | 542,139 (0%) | 0% | 17.4 | 174,294 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 10 Feb 2020 | 10,000 | 552,139 (0%) | 0% | 4.8 | 47,520 | Common Stock |
Sharon Shacham | President & CSO | Sale of securities on an exchange or to another person at price $ 16.93 per share. | 10 Feb 2020 | 10,000 | 743,506 (1%) | 0% | 16.9 | 169,327 | Common Stock |
Sharon Shacham | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share. | 10 Feb 2020 | 10,000 | 753,506 (1%) | 0% | 4.8 | 47,520 | Common Stock |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 153,500 | 153,500 | - | - | Stock Option (right to buy) | |
Michael G. Kauffman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2020 | 57,200 | 57,200 | - | - | Restricted Stock Units |